Cited by 58Liver Diseases and ImmunityOrgan Transplantation Techniques and OutcomesLiver Disease and Transplantation

Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis

Open access
Goldberg, David S., Camp, Amanda, Martinez-Camacho, Alvaro, Forman, Lisa, Fortune, Brett, Reddy, Rajender K.·2013·Liver Transplantation

Abstract

Patients with primary sclerosing cholangitis (PSC) are at increased risk for bacterial cholangitis because of biliary strictures and bile stasis. A subset of PSC patients suffer from repeated episodes of bacterial cholangitis, which can lead to frequent hospitalizations and impaired quality of life. Although waitlist candidates with PSC and bacterial cholangitis frequently receive exception points and/or are referred for living donor transplantation, the impact of bacterial cholangitis on waitlist mortality is unknown. We performed a retrospective cohort study of all adult waitlist candidates with PSC who were listed for initial transplantation between February 27, 2002 and June 1, 2012 at the University of Pennsylvania and the University of Colorado–Denver. During this period, 171 PSC patients were waitlisted for initial transplantation. Before waitlisting, 38.6% (66/171) of the patients had a history of bacterial cholangitis, whereas 28.0% (44/157) of the patients with at least 1 Model for End-Stage Liver Disease update experienced cholangitis on the waitlist. During follow-up, 30 patients (17.5%) were removed from the waitlist for death or clinical deterioration, with 46.7% (14/30) developing cholangiocarcinoma. Overall, 12 of the 82 waitlist candidates (14.6%) who ever had an episode of cholangitis were removed for death or clinical deterioration, whereas 18 of the 89 candidates (20.2%) without cholangitis were removed (P = 0.34 for a comparison of the 2 groups). No patients were removed because of bacterial cholangitis. In multivariate competing-risk models, a history of bacterial cholangitis was not associated with an increased risk of waitlist removal for death or clinical deterioration (subhazard ratio = 0.67, 95% confidence interval = 0.65–0.70, P < 0.001). In summary, waitlist transplant candidates with PSC and bacterial cholangitis do not have an increased risk of waitlist mortality. The data call into question the systematic granting of exception points or referral for living donor transplantation due to a perceived risk of increased waitlist mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/lt.23587

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Transplant candidates with PSC and bacterial cholangitis had no increased risk of waitlist mortality in a study from 2 US transplant centres.

    “However, transplant candidates with PSC and bacterial cholangitis had no increased risk of waitlist mortality in a study from 2 US transplant centres.244”

    From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [244]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Goldberg, D. S., Camp, A., Martinez-Camacho, A., Forman, L., Fortune, B., & Reddy, R. K.
Affiliations
  • University of Pennsylvania (US)
  • University of Colorado Denver (US)
  • Yale New Haven Hospital (US)
Corresponding author
Goldberg, David S.
Venue
Liver Transplantation
Published
2013-03
Volume
19
Issue
3
Pages
250-258
ISSN
1527-6465 (ISSN-L)
OpenAlex
W1559553970
Cited by
58
References
17
Citations by year
2026: 5 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 5 · 2017: 7 · 2016: 4 · 2015: 7 · 2014: 3 · 2013: 6
FWCI
3.23
Type
journal article
Language
en
Open access
Locations
  • Liver Transplantation (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (1-F32-)
  • National Institute of Diabetes and Digestive and Kidney Diseases (F32 1-F32-DK-089694-01, F32DK089694)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
primary sclerosing cholangitis, bacterial cholangitis, waitlist mortality, living donor liver transplantation, cholangiocarcinoma, competing risks, MELD score
MeSH terms
Adult, Cholangitis, Colorado, Female, Humans, Male, Middle Aged, Pennsylvania, Recurrence, Retrospective Studies, Risk Factors, Time Factors, Waiting Lists, Cholangitis, Sclerosing, Multivariate Analysis, Proportional Hazards Models, Liver Transplantation, Risk Assessment, Patient Selection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review